Safety and Efficacy of Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia

被引：0

作者：

Nicholls, Stephen ^{[1
]}

Nelson, Adam ^{[1
]}

Ditmarsch, Marc ^{[2
]}

Kastelein, John ^{[2
]}

Ballantyne, Christie ^{[3
]}

Ray, Kausik ^{[4
]}

Navar, Ann Marie ^{[5
]}

Nissen, Steven ^{[6
]}

Goldberg, Anne ^{[7
]}

Brunham, Liam ^{[8
]}

Wuerdeman, Erin ^{[9
]}

Neild, Annie ^{[10
]}

Kling, Douglas ^{[11
]}

Hsieh, Andrew ^{[12
]}

Ference, Brian ^{[13
]}

Laufs, Ulrich ^{[14
]}

Banach, Maciej ^{[15
]}

Mehran, Roxana ^{[16
]}

Catapano, Alberico ^{[17
]}

Davidson, Michael ^{[2
]}

机构：

[1] Victorian Heart Hosp, Clayton, Vic, Australia

[2] New Amsterdam Pharma, Amsterdam, Netherlands

[3] Baylor Coll Med, Houston, TX 77030 USA

[4] Imperial Coll London, London, England

[5] UT Southwestern Med Ctr, Dallas, TX USA

[6] Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA

[7] Washington Univ, Sch Med, St Louis, MO USA

[8] Univ British C0lumbia, Vancouver, BC, Canada

[9] NewAmsterdam Pharma, Cincinnati, OH USA

[10] NewAmsterdam Pharma, Aventura, FL USA

[11] NewAmsterdam Pharma, Lebanon, NJ USA

[12] Univ Illinois, Long Grove, IL USA

[13] Deep Causal AI, Cambridge, England

[14] Univ Clin Leipzig, Leipzig, Germany

[15] Med Univ Lodz, Lodz, Poland

[16] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

[17] Univ Milan, Milan, Italy

来源：

CIRCULATION | 2024年 / 150卷 / 25期

关键词：

CETP inhibitors; Lipids; Clinical trials; Dyslipidemia; Prevention;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

4171281

引用

页码：E729 / E730

页数：2

共 50 条

[1] Impact of Age on the Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia
Henry N. Ginsberg
Jaakko Tuomilehto
G. Kees Hovingh
Bertrand Cariou
Raul D. Santos
Alan S. Brown
Santosh K. Sanganalmath
Andrew Koren
Desmond Thompson
Frederick J. Raal
Cardiovascular Drugs and Therapy, 2019, 33 : 69 - 76
[2] Impact of Age on the Efficacy and Safety of Alirocumab in Patients With Heterozygous Familial Hypercholesterolemia
Ginsberg, Henry N.
Tuomilehto, Jaakko
Hovingh, G. Kees
Cariou, Bertrand
Santos, Raul D.
Brown, Alan S.
Sanganalmath, Santosh K.
Koren, Andrew T.
Thompson, Desmond E.
Raal, Frederick J.
CIRCULATION, 2017, 136
[3] Impact of Age on the Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia
Ginsberg, Henry N.
Tuomilehto, Jaakko
Hovingh, G. Kees
Cariou, Bertrand
Santos, Raul D.
Brown, Alan S.
Sanganalmath, Santosh K.
Koren, Andrew
Thompson, Desmond
Raal, Frederick J.
CARDIOVASCULAR DRUGS AND THERAPY, 2019, 33 (01) : 69 - 76
[4] Efficacy and safety of lovastatin therapy in adolescent girls with heterozygous familial hypercholesterolemia
Clauss, SB
Holmes, KW
Hopkins, P
Stein, E
Cho, M
Tate, A
Johnson-Levonas, AO
Kwiterovich, PO
PEDIATRICS, 2005, 116 (03) : 682 - 688
[5] Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib in Japanese patients with heterozygous familial hypercholesterolemia
Arai, Hidenori
Teramoto, Tamio
Daida, Hiroyuki
Ikewaki, Katsunori
Maeda, Yuko
Nakagomi, Mariko
Shirakawa, Masayoshi
Kakikawa, Taro
Numaguchi, Hirotaka
Johnson-Levonas, Amy O.
Vaidya, Sanskruti
Blaustein, Robert O.
ATHEROSCLEROSIS, 2016, 249 : 215 - 223
[6] Lp(a) levels in Greek patients with heterozygous familial hypercholesterolemia
Elisaf, M
Bairaktari, H
Siamopoulos, KC
INTERNATIONAL JOURNAL OF CARDIOLOGY, 1996, 53 (03) : 314 - 316
[7] Efficacy and safety of bempedoic acid in patients with heterozygous familial hypercholesterolemia: analysis of pooled patient-level data from phase 3 clinical trials
Duell, Barton
Banach, Maciej
Catapano, Alberico L.
Laufs, Ulrich
Ray, Kausik K.
Mancini, G. B. John
Broestl, Christine
Zhang, Yang
Lei, Lei
Goldberg, Anne C.
JOURNAL OF CLINICAL LIPIDOLOGY, 2024, 18 (02) : e153 - e165
[8] Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia
Gagné, C
Gaudet, D
Bruckert, E
CIRCULATION, 2002, 105 (21) : 2469 - 2475
[9] Efficacy and Safety of Rosuvastatin Therapy for Children With Familial Hypercholesterolemia
Avis, Hans J.
Hutten, Barbara A.
Gagne, Claude
Langslet, Gisle
McCrindle, Brian W.
Wiegman, Albert
Hsia, Judith
Kastelein, John J. P.
Stein, Evan A.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (11) : 1121 - 1126
[10] Bempedoic Acid for Heterozygous Familial Hypercholesterolemia: From Bench to Bedside
Agarwala, Anandita
Quispe, Renato
Goldberg, Anne C.
Michos, Erin D.
DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 : 1955 - 1963

← 1 2 3 4 5 →